{"favorite_id": 10068, "calc_type": "", "dosing": false, "full_title_en": "NAFLD (Non-Alcoholic Fatty Liver Disease) Activity Score", "short_title_en": "NAFLD Activity Score", "medium_description_en": "Diagnoses steatohepatitis, based on histology, in NAFLD patients.", "short_description_en": "Histologic diagnosis of steatohepatitis in NAFLD.", "before_use": "", "instructions_en": "<p>Use in patients who have had liver biopsy for NAFLD.&nbsp;The score should not be used as a surrogate for NASH diagnosis (see&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079483/\" target=\"_blank\" data-saferedirecturl=\"https://www.google.com/url?q=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079483/&amp;source=gmail&amp;ust=1543344851892000&amp;usg=AFQjCNH_2CcQB5GkbqWP1ufrcE0Qm-XdZg\">Brunt and Kleiner 2011</a>&nbsp;for details).</p>", "purpose_en": ["Diagnosis"], "disease_en": ["Acute Pain", "Cirrhosis"], "specialty_en": ["Critical Care", "Family Practice", "Gastroenterology", "Hepatology", "Internal Medicine", "Pathology", "Primary Care"], "chief_complaint_en": ["Abdominal Pain", "Jaundice"], "system_en": ["Endocrine and Metabolic", "Gastrointestinal"], "search_abbreviation_en": ["NAFLD", "liver disease score", "fatty liver disease score", "non-alcoholic fatty liver disease score", "nafld balloon score", "balloon score"], "slug": "nafld-non-alcoholic-fatty-liver-disease-activity-score", "seo": {"meta_description_en": "The NAFLD Activity Score assesses histological injury of patients with NAFLD. ", "keywords_en": "NAFLD, activity score, balloon score, non-alcoholic fatty liver disease, liver disease, liver"}, "content": {"how_to_use": {"use_case_en": "<p>Do you use the&nbsp;NAFLD Activity Score&nbsp;and want to contribute your expertise?&nbsp;<a href=\"https://www.mdcalc.com/join-us\" target=\"_blank\">Join</a>&nbsp;our contributor team!</p>", "pearls_pitfalls_en": "", "why_use_en": ""}, "next_steps": {"advice_en": "<p>Do you use the&nbsp;NAFLD Activity Score and want to contribute your expertise? <a href=\"https://www.mdcalc.com/join-us\" target=\"_blank\">Join</a> our contributor team!</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p dir=\"ltr\">Addition of the selected points:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /></colgroup>\n<tbody>\n<tr>\n<td colspan=\"3\">\n<p dir=\"ltr\"><strong>Variable</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"4\">\n<p dir=\"ltr\">Steatosis (grade): low- to medium-power evaluation of parenchymal involvement by steatosis</p>\n</td>\n<td>\n<p dir=\"ltr\">&lt;5%</p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">5-33%</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">34-66%</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;66%</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"4\">\n<p dir=\"ltr\">Inflammation (lobular): overall assessment of all inflammatory foci</p>\n</td>\n<td>\n<p dir=\"ltr\">No foci</p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1 focus per 200&times; field</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">2\u20104 foci per 200&times; field</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;4 foci per 200&times; field</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"3\">\n<p dir=\"ltr\">Liver cell injury (ballooning)</p>\n</td>\n<td>\n<p dir=\"ltr\">None</p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Few balloon cells</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Many cells/prominent ballooning</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>", "more_info_en": "<p dir=\"ltr\">Interpretation:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"76\" /><col width=\"184\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>NAFLD Activity&nbsp;Score</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Activity*</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n<td>\n<p dir=\"ltr\">No activity</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1&ndash;2</p>\n</td>\n<td>\n<p dir=\"ltr\">Mild activity</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">3&ndash;5</p>\n</td>\n<td>\n<p dir=\"ltr\">Moderate activity</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">6&ndash;8</p>\n</td>\n<td>\n<p dir=\"ltr\">Marked activity</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*Note: the score correlates with steatohepatitis diagnosis, but should not be used to definitively diagnose NASH.</p>\n</div>", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/15915461 ", "text": "Kleiner DE, Brunt EM, Van natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313-21."}], "Other References": [], "Validation": [{"href": "https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.24127 ", "text": "Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-tetri BA. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53(3):810-20. "}, {"href": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2752351", "text": "Kleiner DE, Brunt EM, Wilson LA, et al. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease. JAMA Netw Open. 2019;2(10):e1912565."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. David E. Kleiner", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>David E. Kleiner, MD, PhD, is an anatomical pathologist at the National Cancer Institute. He is also director of clinical operations and chief of the postmortem pathology section at the NIH. Dr. Kleiner\u2019s research focuses primarily on chronic liver disease and transplantation pathology.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-david-e-kleiner.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Kleiner+DE%5BAuthor%5D"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Steatosis grade", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Low- to medium-power evaluation of parenchymal involvement by steatosis", "optional": false, "options": [{"label": "<5%", "value": 0}, {"label": "5-33%", "value": 1}, {"label": "34-66%", "value": 2}, {"label": ">66%", "value": 3}], "name": "stenosis"}, {"type": "radio", "label_en": "Lobular inflammation", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Overall assessment of all inflammatory foci", "optional": false, "options": [{"label": "No foci", "value": 0}, {"label": "1 focus per 200\u00d7 field", "value": 1}, {"label": "2\u20104 foci per 200\u00d7 field", "value": 2}, {"label": ">4 foci per 200\u00d7 field", "value": 3}], "name": "inflam"}, {"type": "radio", "label_en": "Liver cell injury", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Ballooning ", "optional": false, "options": [{"label": "None", "value": 0}, {"label": "Few balloon cells", "value": 1}, {"label": "Many cells/prominent ballooning", "value": 2}], "name": "injury"}], "md5": "", "related_calcs": [{"calcId": 10147, "short_title_en": "UKELD Score", "slug": "united-kingdom-model-end-stage-liver-disease-ukeld"}, {"calcId": 10094, "short_title_en": "GALAD Model for HCC", "slug": "galad-model-hepatocellular-carcinoma-hcc"}, {"calcId": 340, "short_title_en": "Child-Pugh Score", "slug": "child-pugh-score-cirrhosis-mortality"}]}